Ειδήσεις: KALVISTA | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

29/03 08:17 defenseworld.net

Stock Traders Buy High Volume of Call Options on KalVista Pharmaceuticals (NASDAQ:KALV)

KalVista call options unusual trading insider sale CEO stock options

28/03 10:07 defenseworld.net

KalVista Pharmaceuticals (NASDAQ:KALV) Major Shareholder Venrock Healthcare Capital Par Sells 39,986 Shares of Stock

Venrock KalVista share sale SEC filing insider ownership healthcare

28/03 07:50 defenseworld.net

KalVista Pharmaceuticals (NASDAQ:KALV) Upgraded to Buy at Wall Street Zen

KalVista Pharmaceuticals Wall Street Zen buy rating price target Nasdaq pharma

27/03 09:37 defenseworld.net

KalVista Pharmaceuticals (NASDAQ:KALV) Given New $28.00 Price Target at Citizens Jmp

KalVista Pharmaceuticals price target analysts buy rating pharmaceutical stock market outlook

27/03 08:46 defenseworld.net

KalVista Pharmaceuticals (NASDAQ:KALV) Sets New 12-Month High Following Analyst Upgrade

KalVista Pharmaceuticals KALV stock price analyst upgrade buy rating Stifel Nicolaus

27/03 08:46 defenseworld.net

KalVista Pharmaceuticals (NASDAQ:KALV) Sets New 12-Month High Following Analyst Upgrade

KalVista Pharmaceuticals KALV stock price analyst upgrade buy rating Stifel Nicolaus

Loading...